CYTOMEL Drug Patent Profile
✉ Email this page to a colleague
When do Cytomel patents expire, and what generic alternatives are available?
Cytomel is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in CYTOMEL is liothyronine sodium. There are four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cytomel
A generic version of CYTOMEL was approved as liothyronine sodium by XGEN PHARMS on August 17th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYTOMEL?
- What are the global sales for CYTOMEL?
- What is Average Wholesale Price for CYTOMEL?
Summary for CYTOMEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 12 |
| Patent Applications: | 1,189 |
| Drug Prices: | Drug price information for CYTOMEL |
| Drug Sales Revenues: | Drug sales revenues for CYTOMEL |
| What excipients (inactive ingredients) are in CYTOMEL? | CYTOMEL excipients list |
| DailyMed Link: | CYTOMEL at DailyMed |
Recent Clinical Trials for CYTOMEL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Virginia Commonwealth University | Phase 2 |
| Oregon Health and Science University | Phase 1 |
| Johns Hopkins University | Phase 1 |
Pharmacology for CYTOMEL
| Drug Class | l-Triiodothyronine |
US Patents and Regulatory Information for CYTOMEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | CYTOMEL | liothyronine sodium | TABLET;ORAL | 010379-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| King Pharms | CYTOMEL | liothyronine sodium | TABLET;ORAL | 010379-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| King Pharms | CYTOMEL | liothyronine sodium | TABLET;ORAL | 010379-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
